Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Emit® II Plus Buprenorphine Assay

K-Number: K221605 · 2023-07-25

Decision Date2023-07-25
Product CodeDJG
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

Emit® II Plus Buprenorphine Assay is a medical device manufactured by Siemens Healthcare Diagnostics, Inc.. It received FDA 510(k) clearance on 2023-07-25 under approval number K221605. The device is classified under product code DJG. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Emit® II Plus Buprenorphine Assay?

Emit® II Plus Buprenorphine Assay is a medical device that received FDA 510(k) clearance on 2023-07-25. It is manufactured by Siemens Healthcare Diagnostics, Inc.. The 510(k) number is K221605.

When was Emit® II Plus Buprenorphine Assay approved by the FDA?

Emit® II Plus Buprenorphine Assay received FDA 510(k) clearance on 2023-07-25, under approval number K221605.

What company makes Emit® II Plus Buprenorphine Assay?

Emit® II Plus Buprenorphine Assay is manufactured by Siemens Healthcare Diagnostics, Inc..

What is the FDA product code for Emit® II Plus Buprenorphine Assay?

The FDA product code for Emit® II Plus Buprenorphine Assay is DJG.

Other Devices by Siemens Healthcare Diagnostics, Inc.

View all 71 devices →

Related Devices (Code: DJG)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.